Literature DB >> 29379997

Quality of life following vaginal reconstructive versus obliterative surgery for treating advanced pelvic organ prolapse.

Alin Petcharopas1, Supreeya Wongtra-Ngan1, Orawee Chinthakanan2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Although colpocleisis is effective in selected women, the low-morbidity obliterative procedure for treating pelvic organ prolapse (POP) and its impact on postoperative quality of life (QOL) have rarely been studied. Our aim was to assess QOL in women after colpocleisis and compare it with that of women after reconstructive vaginal surgery.
METHODS: This retrospective cohort study included women (aged 35-85 years) with POP who underwent obliterative or reconstructive surgical correction during 2009-2015. Patients who met the inclusion criteria underwent telephone interviews that included the validated Prolapse QOL questionnaire (P-QOL Thai).
RESULTS: Of 295 potential participants, 197 (67%) completed the questionnaire: 93 (47%) with obliterative and 104 (53%) with reconstructive surgery. Most were Thai (95.4%), multiparous (87%), and sexually inactive (76%). Their histories included hysterectomy (12%), incontinence or prolapse surgery (11%), and POP stage 3/4 (77%). Patients undergoing obliterative surgery were significantly older than those undergoing a reconstructive procedure (69 vs 58 years, P < 0.05). The obliterative group had more children, less education, and more advanced POP. There were no significant differences in operative parameters or complications. The obliterative surgery group had a significantly shorter hospital stay: median 2 (range 1-17) days vs 3 (1-20) days (P = 0.016). P-QOL scale revealed significantly less postoperative impairment in the obliterative surgery group (1.75 vs 5.26, P = 0.023). There were no significant differences in other P-QOL domains.
CONCLUSIONS: Colpocleisis improves condition-specific QOL in selected patients with advanced POP and remains an option for this group. Surgeons should consider counseling elderly women with advanced POP about obliterative vaginal surgery.

Entities:  

Keywords:  Colpocleisis; Elderly; Obliterative vaginal surgery; Pelvic organ prolapse; Quality of life

Mesh:

Year:  2018        PMID: 29379997     DOI: 10.1007/s00192-018-3559-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  15 in total

1.  Prevalence of genital prolapse in Thai menopausal women (using new standardization classification).

Authors:  Vorachai Chuenchompoonut; Suvit Bunyavejchevin; Wirach Wisawasukmongchol; Nimit Taechakraichana
Journal:  J Med Assoc Thai       Date:  2005-01

2.  Quality of life scores improve in women undergoing colpocleisis: a pilot study.

Authors:  A Özgür Yeniel; A Mete Ergenoglu; Niyazi Askar; İsmail Mete Itil; Reci Meseri
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-05-11       Impact factor: 2.435

Review 3.  [Colpocleisis: guidelines for clinical practice].

Authors:  X Deffieux; T Thubert; L Donon; J-F Hermieu; L Le Normand; C Trichot
Journal:  Prog Urol       Date:  2016-07       Impact factor: 0.915

Review 4.  Colpocleisis: a review.

Authors:  Mary P FitzGerald; Holly E Richter; Sohail Siddique; Peter Thompson; Halina Zyczynski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-06-28

5.  Body Image, Regret, and Satisfaction 24 Weeks After Colpocleisis: A Multicenter Study.

Authors:  Catrina C Crisp; Nicole M Book; Jacqueline A Cunkelman; Aimee L Tieu; Rachel N Pauls
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 May-Jun       Impact factor: 2.091

6.  Obliterative LeFort colpocleisis in a large group of elderly women.

Authors:  Salomon Zebede; Aimee L Smith; Leon N Plowright; Aparna Hegde; Vivian C Aguilar; G Willy Davila
Journal:  Obstet Gynecol       Date:  2013-02       Impact factor: 7.661

7.  Colpocleisis and urinary incontinence.

Authors:  Mary P FitzGerald; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

8.  Colpocleisis for pelvic organ prolapse: patient goals, quality of life, and satisfaction.

Authors:  K L Hullfish; V E Bovbjerg; W D Steers
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

9.  Body image, regret, and satisfaction following colpocleisis.

Authors:  Catrina C Crisp; Nicole M Book; Aimee L Smith; Jacqueline A Cunkelman; Vivian Mishan; Alejandro D Treszezamsky; Sonia R Adams; Costas Apostolis; Lior Lowenstein; Rachel N Pauls
Journal:  Am J Obstet Gynecol       Date:  2013-05-09       Impact factor: 8.661

10.  [Obliterative vaginal surgery for genital prolapse: a retrospective cases series].

Authors:  T Thubert; A Daché; T Leguilchet; A Benchikh; V Ravery; J-F Hermieu
Journal:  Prog Urol       Date:  2012-11-08       Impact factor: 0.915

View more
  5 in total

1.  The underutilization of obliterative and constrictive surgery in the surgical treatment of pelvic organ prolapse.

Authors:  Tony Bazi
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

2.  Risk factors predicting the loss of functional independence after obliterative procedures for pelvic organ prolapse.

Authors:  Logan Blankenship; Meadow M Good; Carmen Smotherman; Shiva Gautam; Ruchira Singh
Journal:  Int Urogynecol J       Date:  2020-07-10       Impact factor: 2.894

3.  Update in native tissue vaginal vault prolapse repair.

Authors:  Andrea Braga; Maurizio Serati; Stefano Salvatore; Marco Torella; Roberto Pasqualetti; Andrea Papadia; Giorgio Caccia
Journal:  Int Urogynecol J       Date:  2020-06-18       Impact factor: 2.894

Review 4.  How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature.

Authors:  Laetitia Felder; Viola Heinzelmann-Schwarz; Tilemachos Kavvadias
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

Review 5.  Colpocleisis as an obliterative surgery for pelvic organ prolapse: is it still a viable option in the twenty-first century? Narrative review.

Authors:  Magdalena Emilia Grzybowska; Konrad Futyma; Aida Kusiak; Dariusz Grzegorz Wydra
Journal:  Int Urogynecol J       Date:  2021-08-18       Impact factor: 1.932

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.